Authors : Maha Lhaloui; Hassnaa Sarhane; Kaoutar Bahida; Fatimazahra Belouazza; Nouhaila Yartaoui; Amina Etber; Aziz Baydada

Volume/Issue : Volume 10 - 2025, Issue 7 - July

---

Google Scholar : https://tinyurl.com/4f9zp8bh

Scribd : https://tinyurl.com/3m9jh56p

DOI : https://doi.org/10.38124/ijisrt/25jul1408

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

---

Abstract : Invasive lobular carcinoma is often diagnosed at an advanced stage. Its morbidity and mortality are comparable to those of other types of invasive breast carcinoma. The serosal membranes are frequently involved as metastatic sites for this form of breast cancer. Hormone therapy remains the cornerstone of the therapeutic arsenal.

Keywords : Invasive Lobular Carcinoma, Hormonotherapy, Peritoneal Metastasis, Pamectomy.

References :

1. Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003;289:1421—4.
2. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer 2005;93:1046—52.
3. Rakha EA, Ellis IO. Lobular breast carcinoma and its variants. Semin Diagn Pathol 2010;27:49—61.
4. Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996;77:113—20.
5. du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Blamey RW. Invasive lobular carcinomas of the breast —– the prognosis of histopathological subtypes. Br J Cancer 1989;60:605—9
6. Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW. Infiltrating lobular carcinoma of the breast. Histopathology 1982;6:149—61.
7. Li CI, Malone KE, Porter PL, Weiss NS, Tang M-TC, CushingHaugen KL, et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003;289:3254—63.
8. Inoue M, Nakagomi H, Nakada H, Furuya K, Ikegame K, Watanabe H, et al. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer. Breast Cancer 2017;24:667—72.
9. Chamming’s, F. Cancers lobulaires infiltrants : imagerie conventionnelle et gestes interventionnels
10. Marchand, E. Chapitre 14 - Pathologie mammaire.
11. Tardivon, A. Cancer du sein (II). Procédures diagnostiques et thérapeutiques. Cancer Sein.
12. Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S, et al. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer. Cancer 2006;106:35-41.
13. Punglia RS, Morrow M, Winer EP, Harris JR. Local therapy and survival in breast cancer. N Engl J Med 2007;356:2399-405.